The gift includes $10 million to a project to be named the Riccio ALS Accelerator Initiative and $5 million to expand and endow the Riccio Fund for Neuroscience. It is the third and largest donation to the school made by the Riccios.
“This extraordinary gift from the Riccios is transformational,” stated Robert Brown Jr., MD, professor of neurology and director of the program in neurotherapeutics at UMass Medical School. “It will greatly enhance the development of ALS therapies here at UMass Chan Medical School. With members of the RNA Therapeutics Institute, our team in neurology is developing new biologic treatments for ALS, targeting aspects of ALS gene expression.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.